Skip to content

SMART study reaffirms that HIV replication is harmful, even at CD4 counts above 350

Benefit of starting HIV treatment early outweighs the risk of toxicities, SMART study shows

Kenya: government to roll out circumcision

Reducing d4T dose improves mitochondrial toxicity, but not lipoatrophy

Indirect effects on immune activation may partially account for lingering benefits of failed antiretroviral therapy in the brain

Ruling in High Court gives right to free NHS care to refused asylum seekers

Unexpected drug interaction found between Kaletra and rosuvastatin

Clinical staging of HIV disease - featured news report

ART recommended for all with CD4 counts below 350, say South African doctors

Southern African HIV Clinicians' Society: new treatment guidelines

Two cases of HIV and simian foamy virus coinfection reported

Abnormal anal cells and high-risk HPV common in HIV-positive Australians

Daily micronutrients of some benefit for HIV-positive patients receiving TB treatment

Tropism test could show which patients would benefit from starting HIV treatment sooner

New drug users less likely to share needles, have HIV, in Russian study

Breath test could monitor adherence to treatment, potential use for DOTS and clinical trials

BHIVA: No clinical difference seen in first-line treatment response between B and non-B subtypes

Pharmacokinetics of paediatric Triomune fixed-dose formulations appear appropriate in African children